Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Hematology|October 20, 2006
Overexpression of interleukin 21 induces expansion of hematopoietic progenitor cellsKatsutoshi Ozaki, Ai Hishiya, Keiko Hatanaka, et al.
Blood|July 31, 2004
A GTPase-activating protein binds STAT3 and is required for IL-6-induced STAT3 activation and for differentiation of a leukemic cell lineYukio Tonozuka, Yukinori Minoshima, Ying Chun Bao, et al.
Blood|January 15, 2008
AML1 mutations induced MDS and MDS/AML in a mouse BMT modelNaoko Watanabe-Okochi, Jiro Kitaura, Ryoichi Ono, et al.
The Journal of Biological Chemistry|June 20, 2003
Selective cytotoxic mechanism of GTP-14564, a novel tyrosine kinase inhibitor in leukemia cells expressing a constitutively active Fms-like tyrosine kinase 3 (FLT3)Ken Murata, Hidetoshi Kumagai, Toshiyuki Kawashima, et al.
Iscience|November 22, 2021
Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2Junpei Ohtsuka, Masaki Imai, Masayuki Fukumura, et al.
Blood|July 11, 2013
Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cellsRyoichi Ono, Masahiro Masuya, Hideaki Nakajima, et al.
International Journal of Oncology|September 9, 2011
IKAROS isoform 6 enhances BCR-ABL1-mediated proliferation of human CD34+ hematopoietic cells on stromal cellsKei Suzuki, Ryoichi Ono, Kohshi Ohishi, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|October 27, 2025
Development of a Novel Mucosal Vaccine Vector Derived From Human Parainfluenza Virus Type 2 and Its Efficacy as a SARS-CoV-2 Vaccine by Intratracheal Administration Using Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2Akira Kawano, Masamitsu N Asaka, Mitsuo Kawano, et al.
International Journal of Hematology|April 8, 2009
Possible involvement of RasGRP4 in leukemogenesisNaoko Watanabe-Okochi, Toshihiko Oki, Yukiko Komeno, et al.
Scientific Reports|September 11, 2019
A versatile platform technology for recombinant vaccines using non-propagative human parainfluenza virus type 2 vectorJunpei Ohtsuka, Masayuki Fukumura, Wakako Furuyama, et al.
Pageof 6